PNC Financial Services Group
UTHR icon

PNC Financial Services Group’s United Therapeutics UTHR Stock Holding History

PNC Financial Services Group’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.33M Sell
4,304
-93
-2% -$52.4K ﹤0.01% 998
2026
Q1 		$2.61M Buy
4,397
+621
+16% +$309K ﹤0.01% 918
2025
Q4 		$1.84M Buy
3,776
+212
+6% +$98.7K ﹤0.01% 1002
2025
Q3 		$1.49M Buy
3,564
+137
+4% +$46.1K ﹤0.01% 1073
2025
Q2 		$985K Sell
3,427
-632
-16% -$189K ﹤0.01% 1197
2025
Q1 		$1.25M Buy
4,059
+875
+27% +$300K ﹤0.01% 1081
2024
Q4 		$1.12M Buy
3,184
+5
+0.2% +$1.84K ﹤0.01% 1120
2024
Q3 		$1.14M Buy
3,179
+412
+15% +$139K ﹤0.01% 1123
2024
Q2 		$881K Buy
2,767
+183
+7% +$48.4K ﹤0.01% 1193
2024
Q1 		$594K Sell
2,584
-52
-2% -$11.7K ﹤0.01% 1412
2023
Q4 		$580K Buy
2,636
+164
+7% +$37.8K ﹤0.01% 1431
2023
Q3 		$558K Buy
2,472
+239
+11% +$55K ﹤0.01% 1411
2023
Q2 		$493K Buy
2,233
+2
+0.1% +$443 ﹤0.01% 1565
2023
Q1 		$500K Buy
2,231
+140
+7% +$34.5K ﹤0.01% 1541
2022
Q4 		$581K Buy
2,091
+129
+7% +$32.6K ﹤0.01% 1432
2022
Q3 		$411K Buy
1,962
+41
+2% +$9.17K ﹤0.01% 1635
2022
Q2 		$453K Buy
1,921
+30
+2% +$6.1K ﹤0.01% 1588
2022
Q1 		$340K Buy
1,891
+11
+0.6% +$2.1K ﹤0.01% 1928
2021
Q4 		$406K Buy
1,880
+46
+3% +$9.03K ﹤0.01% 1838
2021
Q3 		$339K Sell
1,834
-169
-8% -$33.3K ﹤0.01% 1874
2021
Q2 		$359K Sell
2,003
-545
-21% -$104K ﹤0.01% 1839
2021
Q1 		$427K Sell
2,548
-31
-1% -$5.17K ﹤0.01% 1674
2020
Q4 		$391K Sell
2,579
-296
-10% -$38.8K ﹤0.01% 1649
2020
Q3 		$290K Sell
2,875
-249
-8% -$27.3K ﹤0.01% 1700
2020
Q2 		$379K Sell
3,124
-69
-2% -$7.76K ﹤0.01% 1544
2020
Q1 		$304K Sell
3,193
-27
-0.8% -$2.57K ﹤0.01% 1569
2019
Q4 		$283K Buy
3,220
+180
+6% +$15.8K ﹤0.01% 1849
2019
Q3 		$242K Buy
3,040
+339
+13% +$27.3K ﹤0.01% 2029
2019
Q2 		$210K Sell
2,701
-229
-8% -$21.4K ﹤0.01% 2133
2019
Q1 		$344K Buy
2,930
+152
+5% +$17.7K ﹤0.01% 1835
2018
Q4 		$303K Sell
2,778
-3,630
-57% -$421K ﹤0.01% 1811
2018
Q3 		$819K Sell
6,408
-15
-0.2% -$1.85K ﹤0.01% 1433
2018
Q2 		$727K Buy
6,423
+2,251
+54% +$247K ﹤0.01% 1450
2018
Q1 		$469K Sell
4,172
-1,652
-28% -$210K ﹤0.01% 1658
2017
Q4 		$862K Buy
5,824
+655
+13% +$83.3K ﹤0.01% 1401
2017
Q3 		$606K Buy
5,169
+2,897
+128% +$370K ﹤0.01% 1537
2017
Q2 		$296K Buy
2,272
+180
+9% +$22.5K ﹤0.01% 1903
2017
Q1 		$284K Buy
2,092
+95
+5% +$14.4K ﹤0.01% 1937
2016
Q4 		$286K Sell
1,997
-77
-4% -$9.83K ﹤0.01% 1918
2016
Q3 		$244K Sell
2,074
-203
-9% -$24.4K ﹤0.01% 1977
2016
Q2 		$241K Sell
2,277
-810
-26% -$90.4K ﹤0.01% 1967
2016
Q1 		$345K Sell
3,087
-2,121
-41% -$268K ﹤0.01% 1767
2015
Q4 		$815K Buy
5,208
+443
+9% +$64.5K ﹤0.01% 1298
2015
Q3 		$625K Buy
4,765
+63
+1% +$10.1K ﹤0.01% 1437
2015
Q2 		$818K Sell
4,702
-125
-3% -$22.5K ﹤0.01% 1365
2015
Q1 		$832K Buy
4,827
+656
+16% +$100K ﹤0.01% 1343
2014
Q4 		$541K Sell
4,171
-7,349
-64% -$947K ﹤0.01% 1517
2014
Q3 		$1.48M Buy
11,520
+167
+1% +$17.2K ﹤0.01% 991
2014
Q2 		$1M Buy
11,353
+7,028
+162% +$676K ﹤0.01% 1093
2014
Q1 		$407K Sell
4,325
-462
-10% -$47.3K ﹤0.01% 1522
2013
Q4 		$542K Sell
4,787
-405
-8% -$36.5K ﹤0.01% 1328
2013
Q3 		$410K Buy
5,192
+3,104
+149% +$227K ﹤0.01% 1468
2013
Q2 		$137K Buy
+2,088
New +$135K ﹤0.01% 1948

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

PNC Financial Services Group's UTHR Position: Q2 2026 in Review

PNC Financial Services Group reduced its United Therapeutics (UTHR) stake by 2.1% in Q2 2026, selling an estimated $52.4K and leaving 4,304 shares worth $2.33M. The position accounts for ﹤0.01% of the portfolio, ranked #998.

PNC Financial Services Group first reported a position in UTHR in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.61M in Q1 2026. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • PNC Financial Services Group held 4,304 shares of United Therapeutics worth $2.33M as of Q2 2026.
  • PNC Financial Services Group sold 93 United Therapeutics shares in Q2 2026, an estimated $52.4K.
  • United Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #998 holding.
  • PNC Financial Services Group first reported a position in United Therapeutics in Q2 2013 and has held it in 53 quarters since.
  • PNC Financial Services Group's United Therapeutics position peaked at $2.61M in Q1 2026.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.